Takeda Pharmaceutical Co Ltd
XBER:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
PSE:MOL
|
HU |
|
C
|
Ctac NV
F:TAC
|
NL |
|
Fagerhult AB
F:2F0
|
SE |
|
E
|
Empire State Realty Trust Inc
F:ES9
|
US |
|
P
|
Pylon PCL
SET:PYLON
|
TH |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
F:UK2
|
CN |
|
M
|
MPC Energy Solutions NV
OSE:MPCES
|
NL |
|
United Labels AG
F:ULC
|
DE |
|
Netcall PLC
OTC:NCLLF
|
UK |
|
P
|
Pop Mart International Group Ltd
F:735
|
CN |
|
A
|
Adecoagro SA
F:ACD
|
LU |
|
U
|
United Labels AG
DUS:ULC
|
DE |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.43 EUR with a low forecast of 24.47 EUR and a high forecast of 38.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.43
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.43 EUR with a low forecast of 24.47 EUR and a high forecast of 38.65 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
